Joinn Laboratories(China)Co.,Ltd. (HKG: 6127)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
10.52
+0.24 (2.33%)
Nov 12, 2024, 4:08 PM HKT
-29.40%
Market Cap 14.42B
Revenue (ttm) 2.35B
Net Income (ttm) -1.01M
Shares Out n/a
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date Jun 28, 2024
Volume 5,085,685
Open 10.28
Previous Close 10.28
Day's Range 10.12 - 10.86
52-Week Range 6.31 - 15.92
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 28, 2025

About Joinn Laboratories(China)Co.,Ltd.

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I cli... [Read more]

Sector Healthcare
Founded 1995
Employees 2,510
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6127
Full Company Profile

Financial Performance

In 2023, Joinn Laboratories(China)Co.,Ltd.'s revenue was 2.38 billion, an increase of 4.78% compared to the previous year's 2.27 billion. Earnings were 396.99 million, a decrease of -63.04%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.